Anna Polli
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 50
- Lung Cancer Diagnosis and Treatment 15
- Oncology 42
- Colorectal Cancer Treatments and Studies 19
- Lung Cancer Research Studies 17
- Bone health and treatments 5
- Co-authors
- Alice T. Shaw (28 shared papers)Benjamin Solomon (33 shared papers)G. Piscitelli (6 shared papers)Tony Mok (22 shared papers)Jonathan Webster (2 shared papers)Carlo Ferrari (2 shared papers)Ikram Shah Ismail (2 shared papers)M. F. Scanlon (2 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)Annals of Oncology (13 papers)Journal of Thoracic Oncology (9 papers)European Journal of Cancer (7 papers)Future Oncology (4 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Anna Polli
74 papers receiving 4.1k citations
Anna Polli's Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 1.9k
- Pulmonary and Respiratory Medicine 2.1k
- Cancer Research 747
- Endocrinology, Diabetes and Metabolism 592
- Genetics 925
Countries citing papers authored by Anna Polli
This map shows the geographic impact of Anna Polli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Polli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Polli more than expected).
Fields of papers citing papers by Anna Polli
This network shows the impact of papers produced by Anna Polli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Polli. The network helps show where Anna Polli may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Polli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer Hit paper breakdown → | 2020 | 683 |
| 2 | A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea Hit paper breakdown → | 1994 | 523 |
| 3 | Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases Hit paper breakdown → | 2015 | 491 |
| 4 | 2000 | 431 | |
| 5 | 2000 | 254 | |
| 6 | 2005 | 242 | |
| 7 | 2012 | 140 | |
| 8 | Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study Hit paper breakdown → | 2022 | 138 |
| 9 | 2011 | 136 | |
| 10 | Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study Hit paper breakdown → | 2024 | 132 |
| 11 | 1999 | 96 | |
| 12 | 2022 | 87 | |
| 13 | 2006 | 87 | |
| 14 | 2017 | 85 | |
| 15 | 2012 | 58 | |
| 16 | 1992 | 53 | |
| 17 | 2000 | 53 | |
| 18 | 2012 | 48 | |
| 19 | 2017 | 46 | |
| 20 | 2016 | 42 |
About Anna Polli
Anna Polli is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Cancer Research and Molecular Biology, having authored 81 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (50 papers), Colorectal Cancer Treatments and Studies (19 papers), Lung Cancer Research Studies (17 papers), Lung Cancer Diagnosis and Treatment (15 papers), Estrogen and related hormone effects (15 papers), Cancer Genomics and Diagnostics (9 papers), Melanoma and MAPK Pathways (6 papers) and Bone health and treatments (5 papers). The work is most often cited by research in Oncology (1.9k citations), Pulmonary and Respiratory Medicine (2.1k citations), Cancer Research (747 citations), Endocrinology, Diabetes and Metabolism (592 citations) and Genetics (925 citations). Anna Polli has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Alice T. Shaw, Benjamin Solomon, G. Piscitelli, Tony Mok, Jonathan Webster, Carlo Ferrari, Ikram Shah Ismail, M. F. Scanlon, Dong‐Wan Kim and Giorgio Massimini. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, European Journal of Cancer and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.